World Biosurgery Market - Opportunities and Forecasts, 2014 - 2022)

Category : Healthcare  | Published Date : March-2016 | Pages : 115
enquire Customize Report GET DISCOUNT

Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Various synthetic and biologic products like anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for preventing excessive blood loss or providing adhesion or wound/tissue sealing, and repair of damaged or weakened tissues or bones of a body. These advanced products enhance the work efficiency of physicians by controlling surgery-related difficulties in expensive and complicated surgeries.

The size of global biosurgery market is expected to increase substantially in the near future, owing to high investment, increasing R&D spending, aggressive strategies adopted by top players such as new product launches. Other factors that drive the growth of the biosurgery market are technological advancements (high efficiency products, multi-usage products and plasma based products), availability of multifunctional products, rising number of surgeries owing to the increasing rate of obesity and other lifestyle-related diseases, and increasing sports-related injuries. However, the high cost associated with surgeries, stern regulatory environment for product approval and growing popularity of minimally invasive surgeries are likely to restrict its growth in various regions.

The world biosurgery market was evaluated at $6,912.2 million in 2014, and is estimated to garner $12,758.1 million by 2022, registering a CAGR of 8.1% over the forecast period. The report segments the biosurgery market on the basis of product type, application, source, and geography. On the basis of product type, the market is segmented into anti-adhesive agents, hemostatic agents, surgical sealants, bone graft substitutes, and soft tissue management (mesh/patch). According to application, it is classified into cardiovascular and thoracic, neuro and spine, orthopedic, general, and others surgeries. Others surgery covers urological, gynecological, rhytidectomy, and reconstructive surgeries. Based on the source, it is segmented into natural and synthetic products. Geographic breakdown and a deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.

High investment from top players and increasing R&D spending on multi-usage products (such as fibrin sealants) are likely to provide ample opportunities to the industry players across regions. Recently in 2015, the U.S. FDA approved Infuse bone graft implantation from Medtronic PLC, which is made up of polyetheretherketone compound, for oblique lateral interbody fusion and anterior lumbar interbody fusion. Furthermore, in March 2015, Kuros Biosurgery received a U.S. patent for its synthetic hydrogel technology. It is a combination of bioactivebiomaterial products such as sealant and orthobiologics. A comprehensive competitive analysis and profiles of major industry players such as Johnson & Johnson (Ethicon), Baxter International, Medtronic PLC, Stryker, Atrium Medical (Maquet Getinge Group), C. R. Bard, CryoLife Inc., Haemostasis LLC, Kuros Bioscience, and Sanofi are also provided in this report.


  • A comprehensive analysis of factors that drive and restrict the growth of the world Biosurgery market is provided in this report.
  • The study provides an in-depth analysis of this market with current trends and forecasts to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022, which is likely to enable the stakeholders to capitalize on prevailing growth opportunities.
  • Extensive analysis of this market, by component, helps in understanding the products that are currently used along with the variants which are expected to gain prominence in future.
  • Competitive intelligence among top players helps in understanding the competitive scenario across different geographic locations and the strategies adopted by them to increase their market share across various regions.
  • SWOT analysis highlights the internal and external environment of leading companies for effective strategy formulation.


  • By Product Type

    • Anti-adhesive agents
    • Hemostatic agents
    • Surgical sealing agents
      • Natural surgical sealant
      • Synthetic surgical sealant
    • Bone graft substitutes
      • Cell-based matrices
      • Bone morphogenetic proteins
      • Demineralized bone matrix
      • Synthetic graft extender
    • Soft tissue management (mesh/patch)
      • Biologic mesh/patch
        • Allografts
        • Xenografts
      • Synthetic mesh/patch
  • By Application

    • Cardiovascular and thoracic surgery
    • Neuro- and spine surgery
    • Orthopedic surgery
    • General surgery
    • Others (Reconstructive, Urology, and Gynecology Surgeries)
  • By Source

    • Natural/Biologics products
    • Synthetic products
  • By Geography

    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Others
    • Asia-Pacific
      • Australia
      • Japan
      • India
      • China
      • Others
    • LAMEA
      • Latin America
      • Middle East
      • Africa

Table of Contents


1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models


2.1 CXO perspective

2.1.1 Base case scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario


3.1 Market definition and scope

3.1.1 Top investment pockets
3.1.2 Top winning strategies

3.2 Porters five forces analysis

3.2.1 Bargaining power of suppliers
3.2.2 Bargaining power of buyers
3.2.3 Threats from new entrants
3.2.4 Competitive rivalry
3.2.5 Threats from substitute products

3.3 Market share analysis, 2014
3.4 Drivers

3.4.1 Rising prevalence of chronic diseases and related surgeries
3.4.2 Rising geriatric and obese population
3.4.3 Technological advancements
3.4.4 Aggressive market strategies adopted by top players

3.5 Restraints

3.5.1 High cost associated with surgeries
3.5.2 Strict regulation and reimbursement issues
3.5.3 Lack of awareness in LAMEA region
3.5.4 Increasing popularity of minimally invasive surgeries

3.6 Opportunities

3.6.1 Availability of multifunctional products
3.6.2 Rapidly changing healthcare infrastructure in developing countries


4.1 Overview

4.1.1 Market size and forecast

4.2 Anti-adhesive agents

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Hemostatic agents

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Surgical sealing agents

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Natural/biologics surgical sealant Market size and forecast

4.4.5 Synthetic surgical sealants Market size and forecast

4.5 Bone Graft Substitutes

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.5.4 Cell based matrices MArket size and forecast

4.5.5 Bone morphogenetic proteins MArket size and forecast

4.5.6 Demineralised bone matrix MArket size and forecast

4.5.7 Synthetic grafts extenders MArket size and forecast

4.6 Soft tissue management (mesh/patch)

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Biologics/natural soft tissue management (mesh/patch) MArket size and forecast

4.6.5 Synthetic soft tissue management (mesh/patch) MArket size and forecast


5.1.1 Market size and forecast

5.2 Cardiovascular and thoracic surgery

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast

5.3 Neuro and Spine surgery

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 Orthopaedic surgery

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast

5.5 General surgery

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 Others

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast


6.1 Overview

6.1.1 Market size and forecast

6.2 Biologics Products

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 Synthetics products

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast


7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 Europe

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 Asia Pacific

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast


7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast


8.1 Medtronic PLC

8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Business performance
8.1.4 Key strategic moves and developments
8.1.5 SWOT analysis

8.2 Baxter International Inc.

8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Business performance
8.2.4 Key strategic moves and developments
8.2.5 SWOT analysis

8.3 C. R. Bard Inc.

8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Key strategic moves and developments
8.3.4 Business performance
8.3.5 SWOT analysis

8.4 Johnson and Johnson

8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Business performance
8.4.4 Key strategic moves and developments
8.4.5 SWOT analysis

8.5 Stryker Corporation

8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Business performance
8.5.4 Key strategic moves and developments
8.5.5 SWOT analysis

8.6 Sanofi S.A.

8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Business performance
8.6.4 Key strategic moves and developments
8.6.5 SWOT analysis

8.7 Atrium Medical Corporation (Maquet Getinge Group)

8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Business performance
8.7.4 SWOT analysis

8.8 Hemostasis LLC

8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 SWOT analysis

8.9 Cryolife Inc.

8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Business performance
8.9.4 Key strategic moves and developments
8.9.5 SWOT analysis

8.10 Kuros Bioscience

8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Key strategic moves and developments
8.10.4 SWOT analysis

Publisher Name : Allied Market Research


Please Select Format
Single User :- US $ 4740
Five User:- US $ 5910
Enterprise User:- US $ 8250
Data Pack :- US $ 3840

Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.